Skip to main content
. Author manuscript; available in PMC: 2010 May 3.
Published in final edited form as: JAMA. 2009 Jan 21;301(3):286–294. doi: 10.1001/jama.2008.1022

Table 1.

Clinical Characteristics

Variables Normal n=1784 Mild DD n=785 Moderate/Severe DD n=298
Resting
Age, years 53±11 67±9* 66±11*
Male 964 (54%) 433 (55%) 172 (53%)
Systolic blood pressure, mmHg 123±18 130±19* 131±19*
Pulse pressure, mmHg 48 ±15 54±16* 56±16*
Heart rate, beats/min 74±13ψξ 76±14*ξ 78±13*ψ
Body mass index, kg/m2 27±5ψξ 28±4*ξ 29±6*ψ
History CAD 162 (9%) 138 (18%)* 60 (20%)*
History of diabetes mellitus 107 (6%) 126 (16%)* 57 (18%)*
History of hypertension 676 (38%) 496 (63%)* 232 (71%)*ψ
Current/previous smoker 750 (42%) 368 (47%)* 157 (48%)*
History of hyperlipidemia 1015 (57%) 560 (71%)* 232 (71%)*
Calcium channel blocker 99 (5%) 106 (13%)* 48 (16%)*
Beta-blocker 367 (21%) 252 (32%)* 167 (56%)*ψ
ACE/ARB 294 (16%) 257 (33%)* 113 (38%)*
Peak Exercise
Duration exercise, min 9.7±2.6ψξ 7.6±2.3*ξ 7.0±2.1*ψ
Exercise capacity, METs 10.7±2.6ψξ 8.5±2.3*ξ 8.0±2.1*ψ
Peak heart rate, beats/min 155±21 140±21 132±22
Heart rate increase, beats/min 81±19ψξ 64±18*ξ 64±19*ψ
Systolic blood pressure, mmHg 165±23ψξ 166±24 165±25
Diastolic blood pressure, mmHg 79±12 81±42 78±13

Pairwise comparisons of continuous data performed with analysis of variance using Tukey HSD.

*

p<0.05 compared to patients with normal diastolic function

ψ

p<0.05 compared to patients with mild diastolic function.

ξ

p<0.05 compared to patients with moderate/severe diastolic function.

Data are mean ± SD or numbers with percentages in parentheses. CAD=coronary artery disease, ACE=angiotensin converting enzyme inhibitor,

ARB=angiotensin receptor blocker.

Heart rate increase = peak exercise heart rate-baseline heart rate.